|
|
|
|
 |
|
SENSEX
|
 |
-27.20
|
-0.10%
|
|
26175.75
|
|
|
|
NIFTY
|
 |
-64.77
|
-0.08%
|
|
85641.90
|
|
|
|
Nasdaq
|
 |
151.00
|
0.65%
|
|
23365.69
|
|
|
|
Nikkei 225
|
 |
86.81
|
0.17%
|
|
50253.91
|
|
|
|
FTSE 100
|
 |
26.60
|
0.27%
|
|
9720.50
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cipla |
|
BSE Code |
500087
|
|
ISIN Demat |
INE059A01026
|
|
Book Value (Rs) |
411.56
|
|
|
NSE Code |
CIPLA
|
|
Dividend Yield % |
1.05
|
|
Market Cap (Rs) |
1230881.77
|
|
|
TTM PE(x) |
22.64
|
|
TTM EPS(Rs) |
67.31
|
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
17-08 1935
|
|
Registered Office
|
Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra-400013 .
|
|
ISINNO
|
INE059A01026
|
|
Phone
|
022-24826000
|
|
E-mail
|
contactus@cipla.com |
|
URL
|
www.cipla.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Y K Hamied
|
|
Managing Director
|
Umang Vohra
|
|
Company Secretary
|
Rajendra Chopra
|
|
Listing
|
BSE,NSE,Luxembourg
|
|
|
|
|
|
|
|
|
|
|
|